User profiles for Nargiza Parpieva
Парпиева, Наргиза Нусратовна (NN PARPIEVA)Other name: Parpieva Nargiza Nusratovna Республиканский специализированный научно-практический медицинский центр … Verified email at tbcenter.uz Cited by 2793 |
[HTML][HTML] Treatment and outcomes in children with multidrug-resistant tuberculosis: a systematic review and individual patient data meta-analysis
…, A Mendez-Echevarria, BK Moore, P Nargiza… - PLoS …, 2018 - journals.plos.org
Background An estimated 32,000 children develop multidrug-resistant tuberculosis (MDR-TB;
Mycobacterium tuberculosis resistant to isoniazid and rifampin) each year. Little is known …
Mycobacterium tuberculosis resistant to isoniazid and rifampin) each year. Little is known …
[HTML][HTML] A 24-week, all-oral regimen for rifampin-resistant tuberculosis
…, C Berry, E Kazounis, I Motta, N Parpieva… - … England Journal of …, 2022 - Mass Medical Soc
Background In patients with rifampin-resistant tuberculosis, all-oral treatment regimens that
are more effective, shorter, and have a more acceptable side-effect profile than current …
are more effective, shorter, and have a more acceptable side-effect profile than current …
Standardised shorter regimens versus individualised longer regimens for rifampin-or multidrug-resistant tuberculosis
…, N Ndjeka, J Noeske, N Parpieva… - European …, 2020 - Eur Respiratory Soc
We sought to compare the effectiveness of two World Health Organization (WHO)-recommended
regimens for the treatment of rifampin- or multidrug-resistant (RR/MDR) tuberculosis (TB…
regimens for the treatment of rifampin- or multidrug-resistant (RR/MDR) tuberculosis (TB…
[HTML][HTML] Factors associated with unfavorable treatment outcomes in new and previously treated TB patients in Uzbekistan: a five year countrywide study
…, P Colombani, S Gudmund Hinderaker, N Parpieva… - PloS one, 2015 - journals.plos.org
Background TB is one of the main health priorities in Uzbekistan and relatively high rates of
unfavorable treatment outcomes have recently been reported. This requires closer analysis …
unfavorable treatment outcomes have recently been reported. This requires closer analysis …
[HTML][HTML] Off-label use of bedaquiline in children and adolescents with multidrug-resistant tuberculosis
…, A Skrahina, J Cajazeiro, P Nargiza… - Emerging infectious …, 2017 - ncbi.nlm.nih.gov
We describe 27 children and adolescents< 18 years of age who received bedaquiline during
treatment for multidrug-resistant tuberculosis. We report good treatment responses and no …
treatment for multidrug-resistant tuberculosis. We report good treatment responses and no …
[HTML][HTML] Person-centred care in practice: Perspectives from a short course regimen for multi-drug resistant tuberculosis in Karakalpakstan, Uzbekistan
S Horter, B Stringer, N Gray, N Parpieva… - BMC Infectious …, 2020 - Springer
Introduction Person-centred care, an internationally recognised priority, describes the
involvement of people in their care and treatment decisions, and the consideration of their needs …
involvement of people in their care and treatment decisions, and the consideration of their needs …
[HTML][HTML] Where there is hope: a qualitative study examining patients' adherence to multi-drug resistant tuberculosis treatment in Karakalpakstan, Uzbekistan
…, A Amangeldiev, MN Tillashaikhov, N Parpieva… - BMC Infectious …, 2016 - Springer
Background Treatment for multi-drug resistant tuberculosis (MDR-TB) is lengthy, has severe
side effects, and raises adherence challenges. In the Médecins Sans Frontières (MSF) and …
side effects, and raises adherence challenges. In the Médecins Sans Frontières (MSF) and …
[HTML][HTML] Outcomes of HIV-infected versus HIV-non-infected patients treated for drug-resistance tuberculosis: Multicenter cohort study
Background The emergence of resistance to anti-tuberculosis (DR-TB) drugs and the HIV
epidemic represent a serious threat for reducing the global burden of TB. Although data on HIV…
epidemic represent a serious threat for reducing the global burden of TB. Although data on HIV…
[HTML][HTML] Recurrent tuberculosis and associated factors: A five-year countrywide study in Uzbekistan
J Gadoev, D Asadov, AD Harries, N Parpieva… - PLoS …, 2017 - journals.plos.org
Background In Uzbekistan, despite stable and relatively high tuberculosis treatment success
rates, relatively high rates of recurrent tuberculosis have recently been reported. Recurrent …
rates, relatively high rates of recurrent tuberculosis have recently been reported. Recurrent …
[HTML][HTML] Trends, characteristics and treatment outcomes of patients with drug-resistant tuberculosis in Uzbekistan: 2013–2018
Uzbekistan has a high burden of drug-resistant tuberculosis (TB). Although conventional
treatment for multidrug-resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB) has …
treatment for multidrug-resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB) has …